Menu

Trump Administration Considers Restrictions on Chinese Researchers

The proposed limitations stem from fears of intellectual property theft.

May 2, 2018
Diana Kwon

ISTOCK, TOTOJANG

President Donald Trump’s administration is considering a proposal to prohibit Chinese students and scientists from working on sensitive research at US universities, The New York Times reported this week (April 30).

The proposal stems from fears that researchers from China may steal intellectual secrets. According to the Times, US universities are particularly vulnerable to espionage. Defense Department statistics suggest that, in 2014, academic institutions were the target of almost a quarter of the efforts from foreign countries to access sensitive information.

The restrictions may include certain projects with “military or intelligence value,” such as those involving advanced materials or technologies, the Times reports. The restrictions may also place limitations on some of the visas available for Chinese citizens.

Scientists have expressed alarm at this proposal. “We are concerned about news reports that the U.S. administration is considering further restrictions on visas that could limit the travel of Chinese students and scholars from China to the United States,” Rush Holt, CEO of the American Association for the Advancement of Science, says a statement. “Where specific and confirmed espionage is occurring, action must be taken, but obstructing scientific exchange based on non-specific concerns that could be applied to broad swaths of people is ill-conceived and damaging to American interests.”

Jef Boeke of New York University tells STAT News that it’s likely that the research on genome editing is one of the administration’s concerns. Boeke, who collaborates with researchers from China on an international effort to synthesize a yeast genome, says that the proposed restrictions would be “devastating” for the project. 

Stephen Orlins, president of the National Committee on U.S.-China Relations, tells the Times that placing these limitations on Chinese researchers would be “tragic” for universities in the U.S. “It’s important that we don’t let the security fears overwhelm what has made America great,” he says.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.